المؤلفون: Gu, Xiaowen, Zhang, Lianmei, Sun, Min, Zhou, Ying, Ji, Jinling, Xu, YunFang, You, Jianguo, Deng, Zhikui

المصدر: Journal of Cellular and Molecular Medicine ; volume 28, issue 9 ; ISSN 1582-1838 1582-4934

الاتاحة: http://dx.doi.org/10.1111/jcmm.18310
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.18310

المؤلفون: Zhang, Chengwan, Shen, Li, Wei, Dongping, Thorne, Rick F., Zhang, Xu Dong, Yu, Liang, Chen, Song, Zhu, Yifu, Xu, Ran, Deng, Zhikui, Liu, Xiaoning, Ding, Yihan, Wang, Chunling, Shi, Yuye, Bei, Liye

المساهمون: The University of Newcastle. College of Health, Medicine & Wellbeing, School of Biomedical Sciences and Pharmacy

مصطلحات موضوعية: KDM6A/UTX, YY1, NTRK1/TRKA, CML, imatinib resistance, SDG 3, Sustainable Development Goals

Relation: Theranostics Vol. 11, Issue 6, p. 2691-2705; http://hdl.handle.net/1959.13/1455776; uon:45133

الاتاحة: http://hdl.handle.net/1959.13/1455776

المؤلفون: Tao, Shandong, Song, Lixiao, Deng, Yuan, Chen, Yue, Shi, Yuye, Gan, Yimin, Deng, Zhikui, Ding, Banghe, He, Zhengmei, Wang, Chunling, Yu, Liang

المصدر: OncoTargets and Therapy ; volume Volume 13, page 10559-10566 ; ISSN 1178-6930

الاتاحة: http://dx.doi.org/10.2147/ott.s273172
https://www.dovepress.com/getfile.php?fileID=62630

المؤلفون: Tao,Shandong, Song,Lixiao, Deng,Yuan, Chen,Yue, Shi,Yuye, Gan,Yimin, Deng,Zhikui, Ding,Banghe, He,Zhengmei, Wang,Chunling, Yu,Liang

مصطلحات موضوعية: OncoTargets and Therapy

وصف الملف: text/html

Relation: https://www.dovepress.com/acute-myeloid-leukemia-with-nup98-rarg-gene-fusion-similar-to-acute-pr-peer-reviewed-fulltext-article-OTT

الاتاحة: https://www.dovepress.com/acute-myeloid-leukemia-with-nup98-rarg-gene-fusion-similar-to-acute-pr-peer-reviewed-fulltext-article-OTT

المؤلفون: Li, Fayin, Wang, Xiaodong, Deng, Zhikui, Zhang, Xianlong, Gao, Pengfei, Liu, Hailin

المصدر: Neuropeptides ; volume 72, page 58-64 ; ISSN 0143-4179

الاتاحة: http://dx.doi.org/10.1016/j.npep.2018.10.004
https://api.elsevier.com/content/article/PII:S0143417918300933?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0143417918300933?httpAccept=text/plain

المؤلفون: Deng, Zhikui, Li, Yuanyuan, Li, Yu-feng

المصدر: Tumori Journal ; volume 101, issue 3, page 323-327 ; ISSN 0300-8916 2038-2529

الاتاحة: https://doi.org/10.5301/tj.5000287
https://journals.sagepub.com/doi/pdf/10.5301/tj.5000287
https://journals.sagepub.com/doi/full-xml/10.5301/tj.5000287

المؤلفون: Zuo, Xiaojia, Feng, Jinyi, Ye, Lilin, Xing, Miao, Deng, Zhikui, Gu, Xuefeng, Liu, Dingsheng

المساهمون: Discipline Construction Program of Pudong New District Health Bureau of Shanghai

المصدر: Journal of Hematopathology ; volume 14, issue 4, page 299-307 ; ISSN 1868-9256 1865-5785

الاتاحة: http://dx.doi.org/10.1007/s12308-021-00468-2
https://link.springer.com/content/pdf/10.1007/s12308-021-00468-2.pdf
https://link.springer.com/article/10.1007/s12308-021-00468-2/fulltext.html

المؤلفون: Li, Yu-Feng, Deng, Zhikui, Din, Ban-He, Zhu, Jian-Bin

المصدر: Leukemia & Lymphoma ; volume 53, issue 5, page 934-939 ; ISSN 1042-8194 1029-2403

الاتاحة: http://dx.doi.org/10.3109/10428194.2011.635859
http://www.tandfonline.com/doi/pdf/10.3109/10428194.2011.635859

المؤلفون: Wu, Jingjing, Wei, Bin, Wang, Qian, Ding, Yihan, Deng, Zhikui, Lu, Xueying, Li, Yufeng

المصدر: Cell Biochemistry and Biophysics ; volume 74, issue 2, page 277-283 ; ISSN 1085-9195 1559-0283

الاتاحة: http://dx.doi.org/10.1007/s12013-016-0725-x
http://link.springer.com/content/pdf/10.1007/s12013-016-0725-x.pdf
http://link.springer.com/article/10.1007/s12013-016-0725-x/fulltext.html
http://link.springer.com/content/pdf/10.1007/s12013-016-0725-x

المؤلفون: Li, Yuanyuan, Deng, Zhikui, Zhu, Jiabin, Ding, Banhe, Shi, Yuye, Li, Yufeng

المصدر: Acta Haematologica ; volume 132, issue 2, page 172-176 ; ISSN 0001-5792 1421-9662

الاتاحة: http://dx.doi.org/10.1159/000356742
https://www.karger.com/Article/Pdf/356742

المؤلفون: Li, Yu-Feng, Deng, Zhikui, Din, Ban-He, Zhu, Jian-Bin

المصدر: Leukemia & Lymphoma; May2012, Vol. 53 Issue 5, p934-939, 6p, 5 Charts

مصطلحات موضوعية: IMMUNE system, BONE marrow, ANTINEOPLASTIC agents, ANTIVIRAL agents, CHRONIC myeloid leukemia